NDAINHALATIONLIQUID
Approved
Aug 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ETHRANE (enflurane) is an inhalational anesthetic liquid administered via inhalation for general anesthesia during surgical procedures. It is a volatile halogenated ether that produces rapid induction and emergence from anesthesia, making it a mainstay in operating room anesthesia protocols.
LOE Approaching
Mature product entering late-stage lifecycle with declining market pressure; expect consolidation in manufacturing and supply chain roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ETHRANE offers career opportunities focused on manufacturing excellence, supply chain resilience, and operational efficiency in a legacy product portfolio. Roles emphasize technical expertise, quality management, and process optimization rather than commercial sales or clinical innovation.
Supplier Excellence LeadSr Supervisor
Worked on ETHRANE at Baxter International? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.